| 5989- | Chit, | Chitosan: A review of molecular structure, bioactivities and interactions with the human body and micro-organisms |
| - | Review, | Var, | NA |
| 5991- | Chit, | Chitosan-Based Nanoencapsulated Essential Oils: Potential Leads against Breast Cancer Cells in Preclinical Studies |
| - | Review, | BC, | NA |
| 5999- | Chit, | How chitosan can help against breast cancer |
| - | Review, | BC, | NA |
| 5998- | Chit, | Trial: Chitosan can help reduce AGE levels in patients with prostate cancer. |
| - | Trial, | Pca, | NA |
| 5997- | Chit, | Using immunoadjuvant agent glycated chitosan to enhance anti-cancer stem like cell immunity induced by HIFU |
| - | in-vivo, | Lung, | NA |
| 5996- | Chit, | NEW CHITOSAN-BASED CHEMO PHARMACEUTICAL DELIVERY SYSTEMS FOR TUMOR CANCER TREATMENT: SHORT-REVIEW |
| - | Review, | Var, | NA |
| 5995- | Chit, | CUR, | Enhancement of anticancer activity and drug delivery of chitosan-curcumin nanoparticle via molecular docking and simulation analysis |
| - | vitro+vivo, | Var, | NA |
| 5994- | Chit, | Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action |
| - | Review, | Var, | NA |
| 5993- | Chit, | In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy |
| - | in-vitro, | Var, | NA |
| 5992- | Chit, | Preparation of chitosan nanoparticles for simultaneous drug delivery of dacarbazine and enoxaparin in melanoma |
| - | in-vitro, | Melanoma, | B16-F10 |
| 5990- | Chit, | Chitosan Nanoparticles for Targeted Cancer Therapy: A Review of Stimuli-Responsive, Passive, and Active Targeting Strategies |
| - | Review, | Var, | NA |
| 4478- | Chit, | Chitosan promotes ROS-mediated apoptosis and S phase cell cycle arrest in triple-negative breast cancer cells: evidence for intercalative interaction with genomic DNA |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | T47D |
| 4477- | Chit, | Recent Advances in Chitosan and its Derivatives in Cancer Treatment |
| - | Review, | NA, | NA |
| 4476- | Chit, | Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial |
| - | Trial, | NA, | NA |
| 4475- | Chit, | Cholesterol-lowering properties and safety of chitosan |
| - | Review, | Nor, | NA |
| 4479- | Chit, | Chitosan nanoparticles triggered the induction of ROS-mediated cytoprotective autophagy in cancer cells |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | HCC, | SMMC-7721 cell |
| 4493- | Chit, | Selenate, | Se, | A novel synthetic chitosan selenate (CS) induces apoptosis in A549 lung cancer cells via the Fas/FasL pathway |
| - | in-vitro, | Lung, | A549 |
| 4481- | Chit, | Antioxidant Properties and Redox-Modulating Activity of Chitosan and Its Derivatives: Biomaterials with Application in Cancer Therapy |
| - | Review, | Var, | NA |
| 4490- | Chit, | FA, | Chitosan Nanoparticle-Based Drug Delivery Systems: Advances, Challenges, and Future Perspectives |
| - | Review, | NA, | NA |
| 4489- | Chit, | SeNPs, | Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy |
| - | in-vitro, | GBM, | U87MG |
| 4487- | Chit, | PreB, | Unravelling the Role of Chitin and Chitosan in Prebiotic Activity and Correlation With Cancer: A Narrative Review |
| - | Review, | NA, | NA |
| 4482- | Chit, | Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44 |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Liver, | HepG2 |
| 428- | Chit, | docx, | CUR, | Chitosan-based nanoparticle co-delivery of docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer |
| - | vitro+vivo, | Lung, | H460 | - | vitro+vivo, | Lung, | H1299 | - | vitro+vivo, | Lung, | A549 | - | vitro+vivo, | Lung, | PC9 |
| 6080- | CHL, | VitC, | Protective Effects of Sodium Copper Chlorophyllin and/or Ascorbic Acid Against Barium Chloride-Induced Oxidative Stress in Mouse Brain and Liver |
| - | in-vivo, | Nor, | NA |
| 6072- | CHL, | Low-dose dietary chlorophyll inhibits multi-organ carcinogenesis in the rainbow trout |
| - | in-vivo, | Var, | NA |
| 6066- | CHL, | The chlorophyllin-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cells is associated with ERK deactivation and Cyclin D1 depletion |
| - | in-vitro, | BC, | MCF7 |
| 6078- | CHL, | Update on the bioavailability and chemopreventative mechanisms of dietary chlorophyll derivatives |
| - | Review, | Nor, | NA |
| 6074- | CHL, | Study Protocol of a Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse Glioma (CHROME) |
| - | Study, | GBM, | NA |
| 6070- | CHL, | Preclinical evaluation of sodium copper chlorophyllin: safety, pharmacokinetics, and therapeutic potential in breast cancer chemotherapy and cyclophosphamide-induced bladder toxicity |
| - | in-vitro, | BC, | 4T1 |
| 6071- | CHL, | First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent |
| - | Trial, | Nor, | NA |
| 6081- | CHL, | Enhancing Health Benefits through Chlorophylls and Chlorophyll-Rich Agro-Food: A Comprehensive Review |
| - | Review, | Nor, | NA |
| 6073- | CHL, | GEM, | Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis |
| - | in-vitro, | PC, | NA |
| 6067- | CHL, | Antiproliferative effect of chlorophyllin derived from a traditional Chinese medicine Bombyx mori excreta on human breast cancer MCF-7 cells |
| - | in-vitro, | BC, | MCF7 |
| 6065- | CHL, | Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin |
| - | Review, | HCC, | NA |
| - | vitro+vivo, | BC, | 4T1 |
| 6077- | CHL, | Cancer chemoprevention by dietary chlorophylls: A 12,000-animal dose-dose matrix biomarker and tumor study |
| - | in-vivo, | Var, | NA |
| 6079- | CHL, | Chlorophyllin Modulates Gut Microbiota and Inhibits Intestinal Inflammation to Ameliorate Hepatic Fibrosis in Mice |
| - | in-vivo, | Nor, | NA |
| 6069- | CHL, | PDT, | Anti-Cancer Effect of Chlorophyllin-Assisted Photodynamic Therapy to Induce Apoptosis through Oxidative Stress on Human Cervical Cancer |
| - | in-vitro, | Cerv, | HeLa |
| 6068- | CHL, | Dietary chlorophyllin inhibits the canonical NF-κB signaling pathway and induces intrinsic apoptosis in a hamster model of oral oncogenesis |
| - | in-vivo, | Oral, | NA |
| 6076- | CHL, | Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B(1) pharmacokinetics in human volunteers |
| - | Human, | Nor, | NA |
| 6093- | CHOC, | The relevance of theobromine for the beneficial effects of cocoa consumption |
| - | Review, | Nor, | NA | - | NA, | Asthma, | NA |
| 6094- | CHOC, | Impact of Cocoa Products Intake on Plasma and Urine Metabolites: A Review of Targeted and Non-Targeted Studies in Humans |
| - | Human, | Nor, | NA |
| 6082- | CHOC, | Potential for preventive effects of cocoa and cocoa polyphenols in cancer |
| - | Review, | Var, | NA |
| 6083- | CHOC, | Preventive Effects of Cocoa and Cocoa Antioxidants in Colon Cancer |
| - | Review, | Colon, | NA |
| 6084- | CHOC, | Cocoa Polyphenols and Their Potential Benefits for Human Health |
| - | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | IBD, | NA |
| 6085- | CHOC, | Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model |
| - | in-vivo, | PC, | NA |
| 6086- | CHOC, | Cocoa and Chocolate in Human Health and Disease |
| - | Review, | Var, | NA |
| 6087- | CHOC, | Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial |
| - | Trial, | Nor, | NA |
| 6088- | CHOC, | Effect of chocolate on older patients with cancer in palliative care: a randomised controlled study |
| - | Trial, | Var, | NA |
| - | Trial, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid